Status:
COMPLETED
A Multi-domain Approach for the Characterization and Early Diagnosis of Neurodevelopmental Disorders
Lead Sponsor:
IRCCS Eugenio Medea
Collaborating Sponsors:
Ministry of Health, Italy
Conditions:
Neurodevelopmental Disorders
Eligibility:
All Genders
5-7 years
Phase:
NA
Brief Summary
Diagnosis and characterization of neurodevelopmental disorders are considered challenging processes because of their complexity, multi-factoriality and heterogeneity. The present project will consider...
Eligibility Criteria
Inclusion
- APGAR scores at birth at 1' and 5' \> 7;
- newborn screening otoacoustic emissions in the norm;
- absence of neurological disorders;
- Italian as the language mainly spoken in the family nucleus.
Exclusion
- APGAR scores at birth at 1' and 5' \<= 7;
- newborn screening otoacoustic emissions not in the norm;
- presence of neurological disorders;
- non-Italian native speaker
Key Trial Info
Start Date :
March 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05269927
Start Date
March 1 2016
End Date
May 31 2021
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scientific Institute IRCCS E. Medea
Bosisio Parini, Lecco, Italy, 23842